Buy or sell Harpoon Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Harpoon Therapeutics Stock

Harpoon Therapeutics is a preclinical stage biotechnology company.

About Harpoon Therapeutics Stock

Harpoon Therapeutics is a preclinical stage biotechnology company founded by MPM that is developing a novel class of T cell recruiting antibodies against validated hematologic and solid tumor targets.

Funding History

April 2016$15.0M
May 2017$45.0M
November 2018$70.0M

Management

Vice President

Che-Leung Law

CFO

William E. Picht

Co-Founder

Luke Evnin

President & CEO

Gerald McMahon

SENIOR VICE PRESIDENT

Holger Wesche

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Harpoon Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 140K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo